Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 179,143 | 489,663 | 573,239 | 404,612 |
| Gross Profit | -179,143 | -489,663 | -573,239 | -404,612 |
| Selling General And Administration | 2.6M | 2.3M | 3.2M | 4.0M |
| General And Administrative Expense | 2.6M | 2.3M | 3.2M | 4.0M |
| Other Operating Expenses | 9.6M | 13.3M | 16.2M | 13.9M |
| Operating Expense | 12.2M | 15.5M | 19.4M | 17.8M |
| Operating Income | -12.3M | -16.0M | -20.0M | -18.2M |
| EBIT | -12.3M | -16.0M | -20.0M | -18.2M |
| Interest Income | -- | 44,829 | 62,382 | 15,000 |
| Interest Income Non Operating | -- | 44,829 | 62,382 | 15,000 |
| Net Interest Income | -1,960 | 44,829 | 62,382 | 15,000 |
| Other Income Expense | 31.6M | -9.6M | 1.2M | 34,375 |
| Other Non Operating Income Expenses | 6.8M | 5.0M | 2.6M | 595,804 |
| Special Income Charges | 24.5M | -12.6M | 0.00 | -379,846 |
| Write Off | -- | -- | 693,251 | 450,642 |
| Gain On Sale Of Security | 275,718 | -2.0M | -1.5M | -181,583 |
| Pretax Income | 19.3M | -25.6M | -18.8M | -18.2M |
| Tax Effect Of Unusual Items | 3.7M | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | 19.3M | -25.6M | -18.8M | -18.2M |
| Net Income From Continuing Operation Net Minority Interest | 19.3M | -25.6M | -18.8M | -18.2M |
| Net Income Including Noncontrolling Interests | 19.3M | -25.6M | -18.8M | -18.2M |
| Net Income Common Stockholders | 19.3M | -25.6M | -18.8M | -18.2M |
| Net Income | 19.3M | -25.6M | -18.8M | -18.2M |
| EBITDA | -12.2M | -15.5M | -19.4M | -17.8M |
| Normalized EBITDA | -36.9M | -932,936 | -18.0M | -17.3M |
| Reconciled Depreciation | 179,143 | 489,663 | 573,239 | 404,612 |
| Basic EPS | 0.06 | -0.10 | -0.10 | -0.12 |
| Diluted EPS | 0.06 | -0.10 | -0.10 | -0.12 |
| Basic Average Shares | 316.4M | 265.9M | 195.7M | 154.6M |
| Diluted Average Shares | 340.8M | 265.9M | 195.7M | 154.6M |
| Total Unusual Items | 24.8M | -14.6M | -1.5M | -561,429 |
| Total Unusual Items Excluding Goodwill | 24.8M | -14.6M | -1.5M | -561,429 |
| Tax Rate For Calcs | 0.15 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -1.8M | -11.0M | -17.3M | -17.6M |
| Diluted NI Availto Com Stockholders | 19.3M | -25.6M | -18.8M | -18.2M |
| Gain On Sale Of Business | 24.4M | 0.00 | -- | -- |
| Gain On Sale Of Ppe | 107,125 | 26,941 | 0.00 | -- |
| Impairment Of Capital Assets | 0.00 | 12.6M | 0.00 | -70,796 |
| Net Income Continuous Operations | 19.3M | -25.6M | -18.8M | -18.2M |
| Net Non Operating Interest Income Expense | -1,960 | 44,829 | 62,382 | 15,000 |
| Other Gand A | 880,322 | 624,153 | 683,816 | 864,116 |
| Other Special Charges | -- | -4.7M | -2.6M | -584,421 |
| Other Taxes | -- | -- | 693,251 | 450,642 |
| Reconciled Cost Of Revenue | 179,143 | 489,663 | 573,239 | 404,612 |
| Salaries And Wages | 1.7M | 1.6M | 2.5M | 3.1M |
| Total Expenses | 12.3M | 16.0M | 20.0M | 18.2M |
| Total Other Finance Cost | 1,960 | -44,829 | -- | -- |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 1.2M | 100,573 | 902,238 | 3.1M |
| Cash Cash Equivalents And Short Term Investments | 1.2M | 100,573 | 902,238 | 3.1M |
| Cash Financial | 1.2M | 100,573 | 902,238 | 3.1M |
| Accounts Receivable | 12,734 | 20,404 | -- | -- |
| Receivables | 12,734 | 20,404 | 11,722 | 25,519 |
| Prepaid Assets | 231,514 | 201,355 | 324,634 | 263,408 |
| Current Assets | 1.4M | 322,332 | 1.2M | 3.4M |
| Gross PPE | 9.5M | 9.8M | 22.3M | 22.1M |
| Accumulated Depreciation | -1.4M | -1.4M | -1.1M | -506,412 |
| Net PPE | 8.1M | 8.4M | 21.2M | 21.6M |
| Other Non Current Assets | -- | 1.2M | 986,407 | 1.2M |
| Total Non Current Assets | 8.3M | 10.4M | 24.0M | 25.1M |
| Total Assets | 9.7M | 10.7M | 25.3M | 28.4M |
| Accounts Payable | 631,496 | 1.9M | 951,380 | 1.6M |
| Payables | 1.4M | 24.0M | 18.3M | 14.4M |
| Payables And Accrued Expenses | 631,496 | 1.9M | 18.3M | 14.5M |
| Current Accrued Expenses | -- | -- | 103,000 | 96,000 |
| Other Current Liabilities | 740,855 | 22.1M | -- | 1.00 |
| Current Liabilities | 1.4M | 24.0M | 18.3M | 14.5M |
| Total Non Current Liabilities Net Minority Interest | 526,120 | 2.8M | 2.3M | 2.7M |
| Total Liabilities Net Minority Interest | 1.9M | 26.9M | 20.7M | 17.2M |
| Common Stock | 62.3M | 58.2M | 54.0M | 45.5M |
| Capital Stock | 62.3M | 58.2M | 54.0M | 45.5M |
| Retained Earnings | -63.4M | -82.7M | -57.1M | -38.3M |
| Common Stock Equity | 7.8M | -16.2M | 4.6M | 11.3M |
| Stockholders Equity | 7.8M | -16.2M | 4.6M | 11.3M |
| Total Equity Gross Minority Interest | 7.8M | -16.2M | 4.6M | 11.3M |
| Total Capitalization | 7.8M | -16.2M | 4.6M | 11.3M |
| Net Tangible Assets | 7.8M | -16.2M | 4.6M | 11.3M |
| Tangible Book Value | 7.8M | -16.2M | 4.6M | 11.3M |
| Working Capital | 34,152 | -23.7M | -17.1M | -11.1M |
| Invested Capital | 7.8M | -16.2M | 4.6M | 11.3M |
| Share Issued | 332.5M | 302.5M | 231.5M | 167.4M |
| Ordinary Shares Number | 332.5M | 302.5M | 231.5M | 167.4M |
| Buildings And Improvements | 973,910 | 973,910 | 973,910 | 886,918 |
| Construction In Progress | -- | -- | 0.00 | 0.00 |
| Long Term Provisions | 526,120 | 2.8M | 2.3M | 2.7M |
| Machinery Furniture Equipment | 75,605 | 75,605 | 75,605 | 75,605 |
| Non Current Accounts Receivable | 208,316 | 793,474 | 1.9M | 2.2M |
| Non Current Deferred Assets | -- | -- | -- | 0.00 |
| Other Equity Interest | 8.9M | 8.4M | 7.7M | 4.1M |
| Other Properties | 72,742 | 140,618 | 140,618 | 63,257 |
| Other Receivables | -- | 13,162 | 954.00 | 13,184 |
| Properties | -- | 8.6M | 21.1M | 21.1M |
| Taxes Receivable | -- | 7,242 | 10,768 | 12,335 |
| Total Tax Payable | 740,855 | 22.1M | 17.4M | 12.8M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -4.5M | -5.3M | -13.6M | -15.9M |
| Cash Flow From Continuing Operating Activities | -4.5M | -5.3M | -13.6M | -15.9M |
| Depreciation And Amortization | 179,143 | 489,663 | 573,239 | 404,612 |
| Depreciation Amortization Depletion | 179,143 | 489,663 | 573,239 | 404,612 |
| Stock Based Compensation | 747,564 | 234,208 | 453,446 | 1.5M |
| Change In Working Capital | 6.8M | 10.7M | 6.1M | 465,655 |
| Changes In Account Receivables | -2,108 | -8,682 | 13,797 | 28,354 |
| Change In Receivables | 897,948 | 68,075 | -301,677 | -1.8M |
| Change In Payables And Accrued Expense | 6.0M | 10.5M | 6.5M | 2.4M |
| Change In Payable | 6.0M | 10.5M | 6.5M | 2.4M |
| Other Non Cash Items | -6.5M | -4.7M | -2.6M | -574,880 |
| Capital Expenditure | -- | -- | -282,583 | -3.1M |
| Purchase Of PPE | -- | 0.00 | -282,583 | -3.1M |
| Net PPE Purchase And Sale | 64,161 | 0.00 | -255,685 | -3.1M |
| Purchase Of Business | -3,218 | 0.00 | -- | 0.00 |
| Sale Of Business | -- | -- | -- | 0.00 |
| Sale Of Investment | 874,272 | 0.00 | -- | -- |
| Net Investment Purchase And Sale | 874,272 | 0.00 | -- | -- |
| Investing Cash Flow | 1.6M | 0.00 | -255,685 | -3.1M |
| Cash Flow From Continuing Investing Activities | 1.6M | 0.00 | -255,685 | -3.1M |
| Issuance Of Capital Stock | 3.0M | 4.7M | 12.9M | 18.0M |
| Net Common Stock Issuance | 3.0M | 4.7M | 12.9M | 18.0M |
| Financing Cash Flow | 3.9M | 4.5M | 11.6M | 17.2M |
| Cash Flow From Continuing Financing Activities | 3.9M | 4.5M | 11.6M | 17.2M |
| Changes In Cash | 1.1M | -801,665 | -2.2M | -1.8M |
| Beginning Cash Position | 100,573 | 902,238 | 3.1M | 4.9M |
| End Cash Position | 1.2M | 100,573 | 902,238 | 3.1M |
| Free Cash Flow | -4.5M | -5.3M | -13.8M | -19.0M |
| Amortization Cash Flow | -- | -- | -- | 404,612 |
| Amortization Of Intangibles | -- | -- | -- | 404,612 |
| Asset Impairment Charge | -490,837 | 13.6M | 693,251 | 450,642 |
| Change In Account Payable | -603,099 | 1.1M | -680,732 | 928,334 |
| Change In Income Tax Payable | -- | -- | -- | 1.5M |
| Change In Prepaid Assets | -55,862 | 123,279 | -61,226 | -141,619 |
| Change In Tax Payable | -- | -- | -- | 1.5M |
| Common Stock Issuance | 3.0M | 4.7M | 12.9M | 18.0M |
| Depreciation | 179,143 | 489,663 | 573,239 | 404,612 |
| Gain Loss On Investment Securities | -182,928 | -- | -- | -- |
| Gain Loss On Sale Of Business | -24.4M | 0.00 | -- | -- |
| Gain Loss On Sale Of PPE | 68,814 | 0.00 | 7,209 | -- |
| Net Business Purchase And Sale | -3,218 | 0.00 | -- | 0.00 |
| Net Income From Continuing Operations | 19.3M | -25.6M | -18.8M | -18.2M |
| Net Other Financing Charges | -203,042 | -218,827 | -1.2M | -851,163 |
| Net Other Investing Changes | 674,650 | -- | -- | -- |
| Operating Gains Losses | -24.5M | -- | 7,209 | -- |
| Proceeds From Stock Option Exercised | 1.1M | 0.00 | -- | -- |
| Sale Of PPE | 64,161 | 0.00 | 26,898 | 5,467 |